Goldman Sachs’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.4M | Sell |
82,692
-2,656
| -3% | -$45.1K | ﹤0.01% | 4834 |
|
|
2025
Q4 | $1.6M | Sell |
85,348
-8,327
| -9% | -$126K | ﹤0.01% | 4774 |
|
|
2025
Q3 | $1.2M | Sell |
93,675
-2,942
| -3% | -$44.1K | ﹤0.01% | 4901 |
|
|
2025
Q2 | $1.62M | Sell |
96,617
-16,578
| -15% | -$224K | ﹤0.01% | 4341 |
|
|
2025
Q1 | $1.45M | Sell |
113,195
-11,657
| -9% | -$187K | ﹤0.01% | 4403 |
|
|
2024
Q4 | $2.2M | Buy |
124,852
+43,985
| +54% | +$834K | ﹤0.01% | 4194 |
|
|
2024
Q3 | $1.85M | Buy |
80,867
+29,108
| +56% | +$658K | ﹤0.01% | 4223 |
|
|
2024
Q2 | $1.19M | Buy |
51,759
+17,044
| +49% | +$525K | ﹤0.01% | 4326 |
|
|
2024
Q1 | $1.38M | Buy |
34,715
+18,657
| +116% | +$738K | ﹤0.01% | 4130 |
|
|
2023
Q4 | $635K | Sell |
16,058
-3,291
| -17% | -$138K | ﹤0.01% | 4623 |
|
|
2023
Q3 | $859K | Sell |
19,349
-2,348
| -11% | -$102K | ﹤0.01% | 4376 |
|
|
2023
Q2 | $944K | Buy |
21,697
+1,925
| +10% | +$84.6K | ﹤0.01% | 4376 |
|
|
2023
Q1 | $860K | Sell |
19,772
-9,040
| -31% | -$399K | ﹤0.01% | 4489 |
|
|
2022
Q4 | $1.07M | Sell |
28,812
-6,279
| -18% | -$243K | ﹤0.01% | 4377 |
|
|
2022
Q3 | $1.4M | Sell |
35,091
-5,449
| -13% | -$202K | ﹤0.01% | 4276 |
|
|
2022
Q2 | $1.55M | Sell |
40,540
-420
| -1% | -$15.2K | ﹤0.01% | 4269 |
|
|
2022
Q1 | $1.62M | Buy |
40,960
+7,735
| +23% | +$303K | ﹤0.01% | 4416 |
|
|
2021
Q4 | $1.38M | Buy |
33,225
+1,700
| +5% | +$73.9K | ﹤0.01% | 4575 |
|
|
2021
Q3 | $1.33M | Sell |
31,525
-1,880
| -6% | -$94.7K | ﹤0.01% | 4533 |
|
|
2021
Q2 | $1.53M | Sell |
33,405
-9,219
| -22% | -$438K | ﹤0.01% | 4429 |
|
|
2021
Q1 | $2M | Sell |
42,624
-4,772
| -10% | -$232K | ﹤0.01% | 3986 |
|
|
2020
Q4 | $2.03M | Sell |
47,396
-2,958
| -6% | -$152K | ﹤0.01% | 3720 |
|
|
2020
Q3 | $2.48M | Buy |
50,354
+4,212
| +9% | +$233K | ﹤0.01% | 3423 |
|
|
2020
Q2 | $2.69M | Sell |
46,142
-1,080
| -2% | -$57.1K | ﹤0.01% | 3248 |
|
|
2020
Q1 | $2.15M | Buy |
47,222
+18,048
| +62% | +$1.08M | ﹤0.01% | 3245 |
|
|
2019
Q4 | $1.92M | Sell |
29,174
-2,916
| -9% | -$178K | ﹤0.01% | 3679 |
|
|
2019
Q3 | $1.85M | Buy |
32,090
+17,211
| +116% | +$1.07M | ﹤0.01% | 3585 |
|
|
2019
Q2 | $857K | Buy |
14,879
+3,861
| +35% | +$179K | ﹤0.01% | 4090 |
|
|
2019
Q1 | $425K | Sell |
11,018
-6,858
| -38% | -$269K | ﹤0.01% | 4489 |
|
|
2018
Q4 | $682K | Buy |
17,876
+2,701
| +18% | +$104K | ﹤0.01% | 4196 |
|
|
2018
Q3 | $586K | Buy |
15,175
+7,974
| +111% | +$302K | ﹤0.01% | 4346 |
|
|
2018
Q2 | $269K | Sell |
7,201
-4,671
| -39% | -$163K | ﹤0.01% | 4838 |
|
|
2018
Q1 | $347K | Buy |
11,872
+3,460
| +41% | +$116K | ﹤0.01% | 4707 |
|
|
2017
Q4 | $314K | Buy |
8,412
+3,094
| +58% | +$110K | ﹤0.01% | 5152 |
|
|
2017
Q3 | $200K | Sell |
5,318
-14,149
| -73% | -$444K | ﹤0.01% | 5757 |
|
|
2017
Q2 | $524K | Buy |
19,467
+6,955
| +56% | +$170K | ﹤0.01% | 5058 |
|
|
2017
Q1 | $246K | Sell |
12,512
-1,217
| -9% | -$22.5K | ﹤0.01% | 5590 |
|
|
2016
Q4 | $261K | Buy |
13,729
+1,089
| +9% | +$18K | ﹤0.01% | 5587 |
|
|
2016
Q3 | $206K | Sell |
12,640
-1,004
| -7% | -$15.8K | ﹤0.01% | 5811 |
|
|
2016
Q2 | $187K | Buy |
+13,644
| New | +$192K | ﹤0.01% | 5744 |
|
|
2015
Q3 | – | Sell |
-10,522
| Closed | -$150K | – | 7429 |
|
|
2015
Q2 | $150K | Buy |
+10,522
| New | +$149K | ﹤0.01% | 6368 |
|
Other funds holding NRC
VCM
QI
Goldman Sachs's NRC Position: Q1 2026 in Review
Goldman Sachs reduced its NRC Health Common Stock (NRC) stake by 3.1% in Q1 2026, selling an estimated $45.1K and leaving 82,692 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #4834.
Goldman Sachs first reported a position in NRC in Q2 2015 and has held it in 41 quarters since. The position peaked at $2.69M in Q2 2020. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.
- Goldman Sachs held 82,692 shares of NRC Health Common Stock worth $1.4M as of Q1 2026.
- Goldman Sachs sold 2,656 NRC Health Common Stock shares in Q1 2026, an estimated $45.1K.
- NRC Health Common Stock made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4834 holding.
- Goldman Sachs first reported a position in NRC Health Common Stock in Q2 2015 and has held it in 41 quarters since.
- Goldman Sachs's NRC Health Common Stock position peaked at $2.69M in Q2 2020.
- 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.